Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-25 @ 1:03 PM
NCT ID:
NCT02506959
Group ID:
EG001
Title:
Cohort 2_2nd Auto TP Conditioned With Panobinostat and Gem/Bu/Mel
Description:
Patients receive panobinostat PO QD on days -9 to -2, gemcitabine hydrochloride IV over 4 hours on days -8 and -3, busulfan IV over 3 hours on days -8 to -5, and melphalan IV over 30 minutes on days -3 and -2. Patients then undergo autologous peripheral blood stem cell transplant on day 0.
Autologous Hematopoietic Stem Cell Transplantation: Undergo autologous peripheral blood stem cell transplant
Busulfan: Given IV
Gemcitabine Hydrochloride: Given IV
Melphalan: Given IV
Panobinostat: Given PO
Peripheral Blood Stem Cell Transplantation: Undergo autologous peripheral blood stem cell transplant
Pharmacological Study: Correlative studies
Deaths Number Affected:
17
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
33
Other Number Affected:
30
Other Number At Risk:
33
Study:
NCT02506959
Results Section:
NCT02506959
Adverse Events Module:
NCT02506959